Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Ecansya

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 217Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Processa Enrolls 20th Patient in NGC-Cap Breast Cancer Trial
    Processa Enrolls 20th Patient in NGC-Cap Breast Cancer Trial

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212860/0/en/Processa-Pharmaceuticals-Completes-Enrollment-of-20th-Patient-for-Formal-Interim-Analysis-in-Phase-2-NGC-Cap-Breast-Cancer-Study.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Mira Precision Health Launches Toxnav Advantage At ASCO 2026
    Mira Precision Health Launches Toxnav Advantage At ASCO 2026

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mira-precision-health-based-in-mason-ohio-announces-us-launch-of-toxnav-advantage-at-the-2026-asco-gi-cancers-symposium-302652722.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    Processa Pharma Updates Phase 2 Metastatic Breast Cancer Study
    Processa Pharma Updates Phase 2 Metastatic Breast Cancer Study

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206931/0/en/Processa-Pharmaceuticals-Provides-Clinical-Update-on-Phase-2-Study-in-Metastatic-Breast-Cancer.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Stomach Cancer Awareness Month
    Stomach Cancer Awareness Month

    01 Nov 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/215-stomach-cancer-awareness-month

    PRESS RELEASE
    01 Nov 2025
    Share Share
    Cadonilimab Shows OS Gain In 1st-Line Advanced Gastric Cancer
    Cadonilimab Shows OS Gain In 1st-Line Advanced Gastric Cancer

    19 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/significant-os-benefit-with-cadonilimab-in-first-line-advanced-gastric-cancer-final-analysis-of-compassion-15-presented-at-esmo-2025-302588409.html

    PR NEWSWIRE
    19 Oct 2025
    Share Share
    DYPD Enhances Chemotherapy Safety To Reduce Critical Side Effects
    DYPD Enhances Chemotherapy Safety To Reduce Critical Side Effects

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dpyd-safety-update-reducing-the-risk-of-critical-or-fatal-chemotherapy-side-effects-302586745.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.